RESEARCH TRIANGLE PARK – Raymond Guidotti, a veteran life sciences executive who has lived in the Triangle for the past 24 years, has joined the management team of ApiJect Systems, which is building a nearly $800 million “gigafactory” in RTP for the manufacture of vaccines and injectable medicines.
Guidotti was announced as the Connecticut-based company’s chief operating officer on Thursday. He started his new role March 1.
The project was announced last November.
“As a 24-year resident of the Raleigh-Durham area, Ray will also lead our company’s integration in the area as an active corporate citizen,” said CEO Franco Negron in a statement. “He has already put his hand into the design and execution of our workforce recruitment, training, and retention efforts as our Research Triangle presence takes shape.
“When it comes to building a workforce of 650 from scratch, a plant from the ground up, and a company with world class operations, Ray knows what needs to be done and will guide our outstanding teams to ensure our company’s success today and well into the future,” Negron added.
According to the company, Guidotti will be responsible for construction of the ApioJect campus.
Since 2009, Guidotti had worked with Patheon Pharmaceuticals and Thermo Fisher Scientific>e had served most recently as Group Vice President of Global Engineering, Capacity Planning, and Technical/Operations Services for Pharma Services Group within Thermo Fisher Scientific,